Post-Doctoral Fellow: The National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting a postdoctoral fellow to study individual and environmental factors in drug taking and relapse. The workplace is in the Clinical Pharmacology and Therapeutics Research Branch of NIDA's Intramural Research Program (IRP) located in Baltimore, Maryland. The primary focus is on collecting real-time self-reports of exposure to drug cues and psychosocial stressors via Ecological Momentary Assessment and digital devices to gain a better understanding of drug use and long-term recovery. There will be opportunities to develop independent research projects as well as write manuscripts using existing data.
The successful candidate must have a Ph.D. in Psychology, Public Health/Epidemiology, or a closely related field, with 5 or fewer years of postdoctoral experience. Candidates should be familiar with writing protocols, managing day-to-day implementation of protocol procedures, ensuring quality data acquisition, analyzing multilevel repeated-measures data, and writing manuscripts. The prospective candidate should also have knowledge and experience in substance-abuse research. Proficiency with statistical-analysis software, especially SAS or R, is preferred. Stipend will be commensurate with experience and previous accomplishments.
The fellowship is open to U.S. and foreign citizens.
To apply, please email with CV, statement of research interests, 3 representative publications or working papers, and three letters of recommendation to: email@example.com.
Internal Number: 001
About National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
The mission of the Intramural Research Program (IRP) of the National Institute on Drug Abuse is to conduct state-of-the-art research on basic mechanisms that underlie drug abuse and addiction, and to develop new methods for the treatment of drug abuse and addiction. Research is supported at the molecular, genetic, cellular, animal, and clinical levels and is conceptually integrated, highly innovative, and focused on major problems in the field. The long-term goal of the research is to better understand the biological and behavioral factors contributing to initiation, maintenance, and elimination of drug abuse and addiction (and associated diseases), and to translate this knowledge into improved strategies for preventing, treating, and reducing the negative consequences for the individual and for society caused by drug abuse and addiction. An important aspect of the program is the training of young investigators and career development of more experienced investigators in basic and clinical sciences related to drug abuse research.